Stelzer Laurie

MBX Biosciences, Inc. Common Stock · Director

Stelzer Laurie is listed in public filings as director. This Stelzer Laurie insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include MBX Biosciences, Inc. Common Stock (MBX), PMV Pharmaceuticals, Inc. (PMVP), Spyre Therapeutics, Inc. (SYRE), and Sionna Therapeutics, Inc. (SION). Investors use Stelzer Laurie's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
MBX Biosciences, Inc. Common StockMBX$386k12.5k sharesGrant / ExerciseJun 4, 2026$386.4K12.5k shares$30.91--
PMV Pharmaceuticals, Inc.PMVP$50k42k sharesGrant / ExerciseJun 4, 2026$50.0K42k shares$1.19--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Spyre Therapeutics, Inc.SYRE$582k8k sharesGrant / ExerciseMay 27, 2026$582.0K8k shares$72.51--
MBX Biosciences, Inc. Common StockMBX$1.4M32k sharesGrant / ExerciseJan 20, 2026$1.4M32k shares$43.14--
Sionna Therapeutics, Inc.SION$339k20k sharesGrant / ExerciseJun 12, 2025$339.1K20k shares$16.99--
PMV Pharmaceuticals, Inc.PMVP$32k33.5k sharesGrant / ExerciseJun 5, 2025$31.8K33.5k shares$0.95--
Spyre Therapeutics, Inc.SYRE$389k25k sharesGrant / ExerciseMay 29, 2025$388.8K25k shares$15.55--